Giuseppe Cicala
Messina, 98122, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Safety Profile of Zavegepant in the Treatment of Acute Migraine: Insights from the FDA Adverse Event Monitoring System Database.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 12, 2026
Exploring the Influence of Inflammation on the Pharmacokinetics of Antidepressants and Antipsychotics: A Systematic Review.
Journal: Current neuropharmacology
Published: December 18, 2025
Factors Associated with Parental Vaccine Hesitancy in Childhood Immunization: Insights from a Cross-Sectional Survey in Southern Italy.
Journal: Pharmaceutical research
Published: October 27, 2025
Drugs associated with generalized nonallergic pruritus: A World Health Organization pharmacovigilance database analysis.
Journal: Journal of the American Academy of Dermatology
Published: April 24, 2025
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014-2023).
Journal: Cancers
Published: March 16, 2025
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System.
Journal: European journal of clinical pharmacology
Published: January 13, 2025
Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 18, 2024
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 02, 2024
Exploring machine learning tools in a retrospective case-study of patients with metastatic non-small cell lung cancer treated with first-line immunotherapy: A feasibility single-centre experience.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 01, 2024
Inflammation and depression: A study protocol to dissect pathogenetic mechanisms in the onset, comorbidity and treatment response.
Journal: Brain, behavior, & immunity - health
Published: June 19, 2024
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 16, 2024
Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: January 22, 2024
Last Updated: 09/26/2026